394 related articles for article (PubMed ID: 23327781)
21. Measurement and control of the air contamination generated in a medical cyclotron facility for PET radiopharmaceuticals.
Calandrino R; del Vecchio A; Todde S; Fazio F
Health Phys; 2007 May; 92(5 Suppl):S70-7. PubMed ID: 17440326
[TBL] [Abstract][Full Text] [Related]
22. PET imaging with ⁸⁹Zr: from radiochemistry to the clinic.
Deri MA; Zeglis BM; Francesconi LC; Lewis JS
Nucl Med Biol; 2013 Jan; 40(1):3-14. PubMed ID: 22998840
[TBL] [Abstract][Full Text] [Related]
23. [Positron emission tomography: basic principle and radionuclides/probes for metabolic/functional analysis].
Saga T; Yoshikawa K; Ishizu K
Rinsho Byori; 2007 Jul; 55(7):630-8. PubMed ID: 17718059
[TBL] [Abstract][Full Text] [Related]
24. Assessment of radionuclidic impurities in cyclotron produced (99m)Tc.
Lebeda O; van Lier EJ; Štursa J; Ráliš J; Zyuzin A
Nucl Med Biol; 2012 Nov; 39(8):1286-91. PubMed ID: 22796396
[TBL] [Abstract][Full Text] [Related]
25. The rise of metal radionuclides in medical imaging: copper-64, zirconium-89 and yttrium-86.
Ikotun OF; Lapi SE
Future Med Chem; 2011 Apr; 3(5):599-621. PubMed ID: 21526898
[TBL] [Abstract][Full Text] [Related]
26. Radioisotopic Purity of Sodium Pertechnetate 99mTc Produced with a Medium-Energy Cyclotron: Implications for Internal Radiation Dose, Image Quality, and Release Specifications.
Selivanova SV; Lavallée É; Senta H; Caouette L; Sader JA; van Lier EJ; Zyuzin A; van Lier JE; Guérin B; Turcotte É; Lecomte R
J Nucl Med; 2015 Oct; 56(10):1600-8. PubMed ID: 26205300
[TBL] [Abstract][Full Text] [Related]
27. The next generation of positron emission tomography radiopharmaceuticals in oncology.
Rice SL; Roney CA; Daumar P; Lewis JS
Semin Nucl Med; 2011 Jul; 41(4):265-82. PubMed ID: 21624561
[TBL] [Abstract][Full Text] [Related]
28. Current Perspectives on
Yoon JK; Park BN; Ryu EK; An YS; Lee SJ
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560337
[No Abstract] [Full Text] [Related]
29. Imaging quality of (44)Sc in comparison with five other PET radionuclides using Derenzo phantoms and preclinical PET.
Bunka M; Müller C; Vermeulen C; Haller S; Türler A; Schibli R; van der Meulen NP
Appl Radiat Isot; 2016 Apr; 110():129-133. PubMed ID: 26774390
[TBL] [Abstract][Full Text] [Related]
30. Effective production of ⁶⁵Zn with a PET cyclotron.
Lucconi G; Cicoria G; Pancaldi D; Malizia C; Marengo M
Appl Radiat Isot; 2012 Aug; 70(8):1590-4. PubMed ID: 22732395
[TBL] [Abstract][Full Text] [Related]
31. (86)Y production via (86)Sr(p,n) for PET imaging at a cyclotron.
Sadeghi M; Aboudzadeh M; Zali A; Zeinali B
Appl Radiat Isot; 2009; 67(7-8):1392-6. PubMed ID: 19285420
[TBL] [Abstract][Full Text] [Related]
32. Image quality with non-standard nuclides in PET.
Laforest R; Liu X
Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):151-8. PubMed ID: 18043539
[TBL] [Abstract][Full Text] [Related]
33. Radiopharmaceutical chemistry for positron emission tomography.
Li Z; Conti PS
Adv Drug Deliv Rev; 2010 Aug; 62(11):1031-51. PubMed ID: 20854860
[TBL] [Abstract][Full Text] [Related]
34. Improved production and processing of ⁸⁹Zr using a solution target.
Pandey MK; Bansal A; Engelbrecht HP; Byrne JF; Packard AB; DeGrado TR
Nucl Med Biol; 2016 Jan; 43(1):97-100. PubMed ID: 26471714
[TBL] [Abstract][Full Text] [Related]
35. Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET.
Aerts HJ; Dubois L; Perk L; Vermaelen P; van Dongen GA; Wouters BG; Lambin P
J Nucl Med; 2009 Jan; 50(1):123-31. PubMed ID: 19091906
[TBL] [Abstract][Full Text] [Related]
36. 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals.
Fani M; André JP; Maecke HR
Contrast Media Mol Imaging; 2008; 3(2):67-77. PubMed ID: 18383558
[TBL] [Abstract][Full Text] [Related]
37. Developing new molecular imaging probes for PET.
Serdons K; Verbruggen A; Bormans GM
Methods; 2009 Jun; 48(2):104-11. PubMed ID: 19318126
[TBL] [Abstract][Full Text] [Related]
38.
Dias GM; Ramogida CF; Rousseau J; Zacchia NA; Hoehr C; Schaffer P; Lin KS; Bénard F
Nucl Med Biol; 2018 Mar; 58():1-7. PubMed ID: 29291493
[TBL] [Abstract][Full Text] [Related]
39. Intake risk and dose evaluation methods for workers in radiochemistry labs of a medical cyclotron facility.
Calandrino R; del Vecchio A; Savi A; Todde S; Belloli S
Health Phys; 2009 Oct; 97(4):315-21. PubMed ID: 19741360
[TBL] [Abstract][Full Text] [Related]
40. Radiochemistry, Production Processes, Labeling Methods, and ImmunoPET Imaging Pharmaceuticals of Iodine-124.
Kumar K; Ghosh A
Molecules; 2021 Jan; 26(2):. PubMed ID: 33466827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
